Higher expression of plectin is strongly associated with poor survival in patients with adenocarcinoma (HR = 2.2, P = 5.5e−11, Fig. 6A) and in never smoking lung cancer patients (HR = 3.2, P = 2.8e−5, Fig. 6B). Here, PLEC is linked to lung cancer.